Hepatitis Research Today is a free monthly online journal that collates and summarizes the latest research about Hepatitis, including details on hepatitis a, b, c, causes, symptoms.

Volume 2 (2007), Issue 11 (November)

1. Characterization of hepatitis E-specific cell-mediated immune response using IFN-gamma ELISPOT assay.
   J Immunol Methods, 328(1): 152-61. [Abstract] [Full-text]
2. Immunostimulatory properties and antiviral activity of modified HBV-specific siRNAs.
   Biochem Biophys Res Commun, 364(3): 436-42. [Abstract] [Full-text]
3. The association of human immunodeficiency virus infection with spontaneously resolved hepatitis C virus infection and level of viremia among injection drug users.
   Dig Dis Sci, 52(12): 3423-30. [Abstract] [Full-text]
4. Apolipoprotein-AII concentrations are associated with liver steatosis in patients with chronic hepatitis C.
   Dig Dis Sci, 52(12): 3431-4. [Abstract] [Full-text]
5. Adefovir dipivoxil alone or in combination with lamivudine for three months in patients with lamivudine resistant compensated chronic hepatitis B.
   Dig Dis Sci, 52(12): 3444-7. [Abstract] [Full-text]
6. Rotavirus causes hepatic transaminase elevation.
   Dig Dis Sci, 52(12): 3396-8. [Abstract] [Full-text]
7. Clinical course of hepatitis B virus infection in renal allograft recipients.
   Dig Dis Sci, 52(12): 3440-3. [Abstract] [Full-text]
8. Long-term treatment with the combination of amantadine and ribavirin in hepatitis C nonresponders. A case series.
   Dig Dis Sci, 52(12): 3418-22. [Abstract] [Full-text]
9. Comparative protection against liver inflammation and fibrosis by a selective cyclooxygenase-2 inhibitor and a nonredox-type 5-lipoxygenase inhibitor.
   J Pharmacol Exp Ther, 323(3): 778-86. [Abstract] [Full-text]
10. Hepatitis B virus seropositivity is not associated with increased risk of carotid atherosclerosis in Taiwanese.
    Atherosclerosis, 195(2): 392-7. [Abstract] [Full-text]
11. Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype.
    Aliment Pharmacol Ther, 26(11): 1489-98. [Abstract] [Full-text]
12. Hepatitis C virus and lymphoma.
    J Clin Pathol, 60(12): 1378-83. [Abstract] [Full-text]
13. Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.
    N Engl J Med, 357(22): 2227-36. [Abstract] [Full-text]
14. T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies.
    Lancet Infect Dis, 7(12): 804-13. [Abstract] [Full-text]
15. The design of drugs for HIV and HCV.
    Nat Rev Drug Discov, 6(12): 1001-18. [Abstract] [Full-text]
16. The way forward in HCV treatment--finding the right path.
    Nat Rev Drug Discov, 6(12): 991-1000. [Abstract] [Full-text]
17. Angiogenesis soluble factors as hepatocellular carcinoma noninvasive markers for monitoring hepatitis C virus cirrhotic patients awaiting liver transplantation.
    Transplantation, 84(10): 1262-71. [Abstract] [Full-text]

© 2006-2008 Hepatitis Research Today. All Rights Reserved.